10/21/2025
The first randomized, controlled clinical trial evaluating what is now known as enVista Envy, a continuous full-range of vision IOL technology, marks a major advancement in cataract and refractive surgery.
This innovation has transformed the field by reducing bothersome dysphotopsias such as glare, halos, and starbursts, while maintaining excellent vision across all distances.
This publication represents the collaborative work of 9 surgeons and research teams across 9 clinical sites, supported by the outstanding team at Bausch + Lomb and the professional and organized CRO team at Promedica.
Congratulations to all involved.
This open article compares the visual performance and patient-reported outcomes after bilateral implantation of a new full visual range intraocular lens or its monofocal version.
Read the full article: https://journals.lww.com/jcrs/fulltext/2025/10000/efficacy_and_safety_evaluation_of_a_new_full.6.aspx